{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:53:57Z","timestamp":1762505637050,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.4158\/ep09288.cr","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T21:05:10Z","timestamp":1281992710000},"page":"74-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Iatrogenic Osteoporosis, Bilateral Hip Osteonecrosis, and Secondary Adrenal Suppression in an Hiv-Infected Man Receiving Inhaled Corticosteroids and Ritonavir-Boosted Highly Active Antiretroviral Therapy"],"prefix":"10.1016","volume":"17","author":[{"given":"Nargess","family":"Kaviani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Bukberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Manessis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iven","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP09288.CR_bb0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.idc.2006.09.002","article-title":"Rheumatic manifestation of human immunodeficiency virus infection","volume":"20","author":"Medina","year":"2006","journal-title":"Infect Dis Clin N Am"},{"key":"10.4158\/EP09288.CR_bb0015","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1097\/00002030-200009290-00025","article-title":"Osteonecrosis of the femoral head in HIV-1 patients: Four additional cases","volume":"14","author":"Blangy","year":"2000","journal-title":"AIDS"},{"key":"10.4158\/EP09288.CR_bb0020","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00002030-199906180-00025","article-title":"Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors","volume":"13","author":"Meyer","year":"1999","journal-title":"AIDS"},{"key":"10.4158\/EP09288.CR_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1445-5994.2004.00723.x","article-title":"Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction","volume":"35","author":"Soldatos","year":"2005","journal-title":"Intern Med J"},{"key":"10.4158\/EP09288.CR_bb0030","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1210\/jc.2005-0036","article-title":"Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: Six cases","volume":"90","author":"Samara","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09288.CR_bb0035","doi-asserted-by":"crossref","unstructured":"Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: Lessons for the new millennium. Drug Saf. 2000;11-33.","DOI":"10.2165\/00002018-200023010-00002"},{"key":"10.4158\/EP09288.CR_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00024677-200201050-00001","article-title":"Corticosteroid-induced osteoporosis: A guide to optimum management","volume":"1","author":"Cranney","year":"2002","journal-title":"Treat Endocrinol"},{"key":"10.4158\/EP09288.CR_bb0045","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"10","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"10.4158\/EP09288.CR_bb0050","first-page":"S203","article-title":"Osteoporosis in human immunodeficiency infected patients","volume":"43","author":"Medina","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.4158\/EP09288.CR_bb0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00001","article-title":"Guidelines for using antiretroviral agents among HIV-infected adults and adolescents","volume":"137","author":"Dybul","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP09288.CR_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jac\/dkh029","article-title":"Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients","volume":"53","author":"Zeldin","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.4158\/EP09288.CR_bb0065","first-page":"20","article-title":"Osteoporosis in older men: Discovering when and how to treat it","volume":"54","author":"Siddiqui","year":"1999","journal-title":"Geriatrics"},{"key":"10.4158\/EP09288.CR_bb0070","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic Adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP09288.CR_bb0075","first-page":"601","article-title":"Osteonecrosis and human immunodeficiency virus infection","volume":"24","author":"Rademaker","year":"1997","journal-title":"J Rheumatol"},{"key":"10.4158\/EP09288.CR_bb0080","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1517\/14656566.8.13.2077","article-title":"Non-corticosteroid therapy for the long-term control of asthma","volume":"8","author":"Kelly","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.4158\/EP09288.CR_bb0085","first-page":"575","article-title":"Prevention, diagnosis, and management of osteoporosis-related fracture: A multifactoral osteopathic approach","volume":"108","author":"Gronholz","year":"2008","journal-title":"J Am Osteopath Assoc"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2040864X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2040864X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/0613478GQ2Q72H72.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:52:08Z","timestamp":1761515528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2040864X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1530891X2040864X"],"URL":"https:\/\/doi.org\/10.4158\/ep09288.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iatrogenic Osteoporosis, Bilateral Hip Osteonecrosis, and Secondary Adrenal Suppression in an Hiv-Infected Man Receiving Inhaled Corticosteroids and Ritonavir-Boosted Highly Active Antiretroviral Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP09288.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}